EUVIMEDEUVIMED entdecken
Crossref

Treatment of Inherited Platelet Disorders: Current Status and Future Options

Caroline Bargehr, Ralf Knöfler, Werner Streif

Hämostaseologie · 01.08.2023 · 43 (04) · 261-270

DOI: 10.1055/a-2080-6602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.08.2023. Verfasst von Caroline Bargehr und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics 1, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Blood Platelet Disorders, Hemophilia A, Hemostatics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited platelet disorders (IPDs) comprise a heterogeneous group of entities that manifest with variable bleeding tendencies. For successful treatment, the underlying platelet disorder, bleeding severity and location, age, and sex must be considered in the broader clinical context. Previous information from the AWMF S2K guideline #086–004 (www.awmf.org) is evaluated for validity and supplemented by information of new available and future treatment options and clinical scenarios that need specific measures. Special attention is given to the treatment of menorrhagia and risk management during pregnancy in women with IPDs. Established treatment options of IPDs include local hemostatic treatment, tranexamic acid, desmopressin, platelet concentrates, and recombinant activated factor VII. Hematopoietic stem cell therapy is a curative approach for selected patients. We also provide an outlook on promising new therapies. These include autologous hematopoietic stem cell gene therapy, artificial platelets and nanoparticles, and various other procoagulant treatments that are currently tested in clinical trials in the context of hemophilia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Platelet DisordersHemophilia AHemostaticsPregnancyHumansFemaleBlood PlateletsHematopoietic Stem Cells

Substanzen

Hemostatics

Autor:innen und Institutionen

  • Department of Paediatrics 1, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Paediatric Haemostaseology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.

Zitieren

APA

Bargehr, C., Knöfler, R., & Streif, W. (2023). Treatment of Inherited Platelet Disorders: Current Status and Future Options. Hämostaseologie, 43(04), 261-270. https://doi.org/10.1055/a-2080-6602

Vancouver

Bargehr C, Knöfler R, Streif W. Treatment of Inherited Platelet Disorders: Current Status and Future Options. Hämostaseologie. 2023;43(04):261-270. doi:10.1055/a-2080-6602

BibTeX
@article{Bargehr2023,
  author = {Bargehr, Caroline and Knöfler, Ralf and Streif, Werner},
  title = {Treatment of Inherited Platelet Disorders: Current Status and Future Options},
  journal = {Hämostaseologie},
  year = {2023},
  volume = {43},
  number = {04},
  pages = {261--270},
  doi = {10.1055/a-2080-6602}
}
Kostenlos starten →